Qiming Venture Partners

Activity from announced rounds

All recorded activity
Rounds participated in
12
Confirmed lead rounds
2
9 roles undisclosed
New companies
10
First participation on record · 2 follow-on
Funding in participating rounds
$962.8M
10 disclosed · full round size, not this investor’s share

By stage

Series A3
Undisclosed3
Seed2
Series B2
Series C+2

By primary sector

Biotech6
Hardware3
Healthtech2
AI1

By country

China10
Singapore1
United States1

Rounds

12 in all activity
Transtreams Technology

Transtreams Technology develops video-processing chips and AI hardware for cloud platforms and edge-computing applications.

CN¥1BSeries B
Lead
AusperBio

Develops oligonucleotide therapeutics targeting chronic hepatitis B

$120MSeries C
Role not disclosed
Vivacta Biotechnology

Develops in vivo CAR-T cell therapies for cancer and autoimmune diseases

$50MSeries A+
Role not disclosed
Pulnovo Medical

Develops interventional therapies for pulmonary hypertension and heart failure

$100MStrategic
Role not disclosed
Syneron Bio

Develops intelligent platform-driven macrocyclic peptide drug discovery

$150MSeries B
Role not disclosed
StairMed

Develops minimally invasive implantable brain-machine interfaces (BMI) for neurological diseases

CN¥500MStrategic
Role not disclosed
ShengShu Technology

Develops multimodal foundation models for video generation and AI productivity

CN¥600MSeries A
Role not disclosed
Oricell Therapeutics

Develops next-generation cell therapies for oncology and immunology

$70MSeries C1
Role not disclosed
HOUMO.AI

Chinese chip developer building compute-in-memory processors and hardware for running AI models on local devices.

Participant
HOUMO.AI

Chinese chip developer building compute-in-memory processors and hardware for running AI models on local devices.

Lead